Sutro Biopharma’s Zero‑Cost Insider Option Surge Signals Strategic Confidence Ahead of 2027 Milestones
New zero‑price stock options to Sutro Biopharma insiders signal confidence and modest dilution—watch 2027 exercise timing for potential price shifts.
3 minutes to read